In focus · trending topic

Radius Health

2 stories · following the connections

Radius Health Presents Positive Data for the ACTIVExtend BMD Responder Analysis for TYMLOS™ (abaloparatide) Injection at ENDO 2018 Annual Meeting

By Nasdaq OMXMar 17, 2018, 4:30 PM UTC

Radius Health to Present at ENDO 2018 Including Results of the ACTIVExtend BMD Responder Analysis for TYMLOS™ (abaloparatide) Injection

By Nasdaq OMXMar 12, 2018, 8:30 PM UTC